Delta-Fly Pharma, Inc.JP:4598

Market cap

¥4.7B

P/E ratio

	Mar 31, 2017	Mar 31, 2018	Mar 31, 2019	Mar 31, 2020	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024
Cash and deposits	-	781	3,508	1,944	2,089	1,268	844	1,417
Prepaid expenses	-	2	10	9	7	6	3	3
Other	-	49	14	53	20	7	19	13
Current assets	-	832	3,532	2,116	2,115	1,281	866	1,433
Buildings	-	28	29	29	29	29	28	28
Accumulated depreciation	-	-2	-3	-4	-5	-6	-6	-7
Buildings, net	-	25	26	25	24	23	22	21
Structures	-	-	-	2	2	2	2	2
Accumulated depreciation	-	-	-	-0	-0	-1	-1	-1
Structures, net	-	-	-	2	1	1	1	1
Tools, furniture and fixtures	-	1	1	3	3	3	4	5
Accumulated depreciation	-	-1	-1	-1	-2	-3	-3	-3
Tools, furniture and fixtures, net	-	-	0	1	1	1	1	1
Land	-	6	6	15	15	15	15	15
Property, plant and equipment	-	31	32	43	42	40	39	38
Guarantee deposits	-	1	3	3	3	3	2	2
Long-term prepaid expenses	-	0	1	0	1	1	-	1
Other	-	-	-	-	-	-	0	0
Investments and other assets	-	1	4	3	4	4	2	3
Non-current assets	-	32	35	46	46	44	41	41
Assets	-	864	3,567	2,162	2,161	1,324	907	1,474
Accounts payable - other	-	18	26	80	66	69	90	207
Income taxes payable	-	2	23	19	15	20	24	31
Deposits received	-	1	2	2	2	2	2	3
Current liabilities	-	29	57	106	82	91	116	241
Liabilities	-	42	63	106	82	91	116	241
Share capital	-	1,118	2,795	2,849	3,291	3,352	3,795	4,731
Legal capital surplus	-	1,098	2,775	2,829	3,271	3,332	3,775	4,711
Capital surplus	-	1,098	2,775	2,829	3,271	3,332	3,775	4,711
Retained earnings brought forward	-	-1,393	-2,066	-3,622	-4,485	-5,452	-6,781	-8,210
Retained earnings	-	-1,393	-2,066	-3,622	-4,485	-5,452	-6,781	-8,210
Treasury shares	-	-	-	-0	-0	-0	-0	-0
Shareholders' equity	-	822	3,504	2,056	2,077	1,232	789	1,232
Share acquisition rights	-	-	-	-	1	1	2	1
Net assets	769	822	3,504	2,056	2,079	1,233	791	1,233
Liabilities and net assets	-	864	3,567	2,162	2,161	1,324	907	1,474